(CIDRAP News) The National Institutes of Health (NIH) yesterday announced it has awarded contracts, which could total $150 million over 5 years, to four companies to develop broad-spectrum therapies that could help the nation respond to a bioterror attack or other public health emergency.
(CIDRAP News) A comprehensive review of the nation's tools for reducing the impact of a biological weapons attack or other public health emergencyprompted in part by last fall's delays in delivery of the pandemic H1N1 vaccineis due to get under way in the next few weeks with a pair of conferences.
(CIDRAP News) – Emergent BioSolutions announced today that it has received a $29.7 million contract from the federal government to continue work on another of its next-generation anthrax vaccine candidates.
(CIDRAP News) US Navy and Air Force officials recently reported a suspension of work in their biodefense laboratories to allow a thorough review of safety procedures, following the Army's announcement in early August that it would review security measures at the lab that housed the work of the late Bruce E. Ivins, whom federal officials believe played a role in the 2001 anthrax attacks.
(CIDRAP News) – The US government recently awarded contracts totaling about $34 million to two companies for development of drugs to treat pneumonic plague, tularemia, and anthrax, three of the diseases terrorists are deemed most likely to try to exploit.
(CIDRAP News) – Combining vaccination with 14 days of antibiotic therapy after exposure to airborne anthrax may be an alternative to the current recommendation of 60 days of antibiotics alone, according to an animal study reported in the Proceedings of the National Academy of Sciences.
Aug 11, 2004 (CIDRAP News) Government officials and scientists yesterday recognized the formal opening of construction on a laboratory that will house research on the most dangerous emerging infectious diseases and potential bioterrorism agents.